アプタマー アフェレシス 核酸医薬の開発|タグシクス・バイオ株式会社

News

rss
2017.10.23
Information Oct 16th We have moved to Tokyo University Komaba campus.
2017.10.7
Event Presentation schedule in November
2017.10.7
Event Presentation schedule in October
2017.2.1
News Release TAGCyx has executed a research and development collaboration agreement with a European biopharma company in February. The partnership will continue for 2 years which is extendable with mutual agreement and will apply the TAGcyx platform towards the identificatio
2016.8.31
News Release TagCyx announces the completion of 500 million Japanese Yen (US$ 4.9 Million, as of Aug. 31, 2016) private financing, led by The University of Tokyo Edge Capital as a lead investor, and SMBC Venture Capital, Nissay Capital CO., LTD. (Aug 2016)